Moneycontrol PRO

Followers

0
0
3
3
.
2
2
5
5
6
6
2.30 (0.35%)

As on 17 Sep, 2025 | 10:40

Open Trading A/c
Day Range
648.50
655.00
LH
52 Week Range
511.40
842.00
LH
Volume
* i
Bid / Ask
22,059.00
651.65 / 1.00

Supriya Lifescience Announcements

Enclosed herewith is a copy of Newspaper Publication regarding intimation of dispatch of Annual Report, AGM Notice and E-voting Instructions.

02 Sep, 2025 | 02:34pm • Source: BSE

Enclosed herewith is the Letter under Regulation 36 (1) of SEBI (LODR)Regulations, 2015, dispatched by the Company to the Shareholders whose email ids are not...

02 Sep, 2025 | 02:29pm • Source: NSE

Enclosed herewith is the Letter dispatched by the Company to the Shareholders whose email ids are not registered with the Company / Depositories / RTA.Kindly...

02 Sep, 2025 | 02:25pm • Source: BSE

Business Responsibility and Sustainability Report of the Company forming part of Annual Report for FY 2024-25 is enclosed herewith.

01 Sep, 2025 | 07:28pm • Source: BSE

Annual Report of the Company for FY 2024-25 is enclosed herewith.

01 Sep, 2025 | 07:17pm • Source: BSE

Enclosed herewith is the Notice convening the 17th Annual General Meeting of Members of the Company scheduled to be held on Wednesday, September 24, 2025...

01 Sep, 2025 | 07:06pm • Source: BSE

Newspaper extract enclosed herewith.

01 Sep, 2025 | 01:32pm • Source: BSE

Intimation of Record date of the Company for 17th AGM scheduled on September 24, 2025 is attached.Request you to kindly take the same on records.

30 Aug, 2025 | 05:24pm • Source: BSE

Please find Transcript for the Earnings Call held on August 14, 2025.

19 Aug, 2025 | 02:53pm • Source: BSE

Investor Presentation for the quarter ended June 30, 2025

13 Aug, 2025 | 06:28pm • Source: BSE

The Company at its meeting held on August 13, 2025 has approved revised policy/code of the Company.

13 Aug, 2025 | 06:14pm • Source: BSE

Unaudited Financial Results for the quarter ended June 30, 2025.Kindly take the same on record.

13 Aug, 2025 | 06:00pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the...

13 Aug, 2025 | 05:48pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held...

07 Aug, 2025 | 05:44pm • Source: BSE

Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and...

06 Aug, 2025 | 07:28pm • Source: BSE

Company has provided Clarification regarding Demat requests received erroneously from Shareholders of Supriya Pharmaceuticals Limited which is not related to Supriya Lifescience Limited.

23 Jul, 2025 | 05:33pm • Source: BSE

Pursuant to relevant provisions of the SEBI (LODR) Regulations, 2015, we would like to inform you that the officials of our Company will be interacting...

18 Jul, 2025 | 05:19pm • Source: BSE

Pursuant to relevant provisions of the SEBI (LODR) Regulations, 2015, we would like to inform you that the officials of our Company will be interacting...

17 Jul, 2025 | 05:19pm • Source: BSE

Please find enclosed herewith duly signed certificate issued by MUFG Intime India Private Limited, our RTA, confirming compliance under Regulation 74(5) of SEBI (DP) Regulations,...

11 Jul, 2025 | 10:39am • Source: BSE

Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 for details of Show cause cum demand notice received from Office of the Commissioner of...

01 Jul, 2025 | 04:47pm • Source: BSE